Augusto_Valdivia retweeted
Remarkable results from SBRT +/- immunotherapy for unresected stage I-II NSCLC. No benefit from adding
IO & surgery remains standard of care for fit pts w stage I-II, EFS of ~30m w SBRT vs 46-65m for much more advanced disease in trials of neoadj IO #lcsm ascopubs.org/doi/10.1200/JC…
IO & surgery remains standard of care for fit pts w stage I-II, EFS of ~30m w SBRT vs 46-65m for much more advanced disease in trials of neoadj IO #lcsm ascopubs.org/doi/10.1200/JC…
7
18
47
12,039
Augusto_Valdivia retweeted
ETOP 18-21 AMAZE-lung trial 1st prospective trial. exploring a triplet biologic combination targeting EGFR, MET, and VEGF in acquired resistance to third-generation EGFR TKIs. @etop_ibcsg @gecp_org @Hospital_FJD @quironsalud @IIS-FJD. @OncoAlert . #LCSM
sciencedirect.com/science/articl…
sciencedirect.com/science/articl…
0
9
23
1,638
Augusto_Valdivia retweeted
💡 Thinking about coming to the #US for a medical fellowship?
I put together the guide I wish I’d had when I started:
#USMLE
#ECFMG
#Steps
📌 Applications, visas, fellowships, and the bureaucracy nobody explains.
A practical roadmap for international doctors 🇺🇸🩺
📚 Here in English👇🏽
amazon.com/dp/B0HLRQSFQX
📚 Here in Spanish 👇🏽
amazon.com/dp/B0HLZ7PQMP
I put together the guide I wish I’d had when I started:
#USMLE
#ECFMG
#Steps
📌 Applications, visas, fellowships, and the bureaucracy nobody explains.
A practical roadmap for international doctors 🇺🇸🩺
📚 Here in English👇🏽
amazon.com/dp/B0HLRQSFQX
📚 Here in Spanish 👇🏽
amazon.com/dp/B0HLZ7PQMP
2
11
25
2,460
Augusto_Valdivia retweeted
Hoy he entregado otra revisión por pares. Sin cobrar, como casi todos y sacándolo del tiempo personal.
Mañana hacen huelga, por primera vez en 200 años, quienes editan The Lancet
Algo está cambiando.
Unos y otros sostenemos la calidad de lo que se publica. Merecemos que se reconozca.
researchprofessionalnews.com/rr-news-uk-ope…
Mañana hacen huelga, por primera vez en 200 años, quienes editan The Lancet
Algo está cambiando.
Unos y otros sostenemos la calidad de lo que se publica. Merecemos que se reconozca.
researchprofessionalnews.com/rr-news-uk-ope…
22
107
462
37,672
Augusto_Valdivia retweeted
💬 “El futuro está en los ensayos clínicos fase 1.”
Irene Braña, jefa del Grupo de Cáncer de Cabeza y Cuello del #VHIO, comparte cómo una reflexión del Dr. Josep Baselga marcó su interés por la investigación clínica y el desarrollo precoz de fármacos.
➡️ youtu.be/E3IhQB08ofc
lY
#20VHIO
Irene Braña, jefa del Grupo de Cáncer de Cabeza y Cuello del #VHIO, comparte cómo una reflexión del Dr. Josep Baselga marcó su interés por la investigación clínica y el desarrollo precoz de fármacos.
➡️ youtu.be/E3IhQB08ofc
lY
#20VHIO
0
3
10
537
Augusto_Valdivia retweeted
💬 “Tots vam somiar una mica a fer una oncologia d’excel·lència per als nostres pacients.”
@EnriquetaFelip, codirectora de Recerca Clínica i cap del Grup de Tumors Toràcics del #VHIO, parla de medicina de precisió, treball en equip i recerca orientada als pacients.
▶️ Vídeo ps://t.co/CEk5k6qTNl
#20VHIO @vallhebron
@EnriquetaFelip, codirectora de Recerca Clínica i cap del Grup de Tumors Toràcics del #VHIO, parla de medicina de precisió, treball en equip i recerca orientada als pacients.
▶️ Vídeo ps://t.co/CEk5k6qTNl
#20VHIO @vallhebron
1
5
14
1,331
Augusto_Valdivia retweeted
👉Seguimos avanzando con el #XIVCursoCompetenciasGECP.
Gracias a los docentes que están participando por compartir su experiencia, conocimiento y compromiso con la formación.
¡Un placer seguir aprendiendo juntos!
@Annestival @bmassutis @ManuelDomine @ECarcereny
Gracias a los docentes que están participando por compartir su experiencia, conocimiento y compromiso con la formación.
¡Un placer seguir aprendiendo juntos!
@Annestival @bmassutis @ManuelDomine @ECarcereny
2
4
9
1,023
Augusto_Valdivia retweeted
🚨 Key issues w/ @NatureMedicine time-of-day IO paper:
• Protocol v1 (Jan 2022) cites 2024 refs → timeline error
• CT.gov record changed: randomized → observational → revised
• Protocol-registry mismatch (endpoints, n, ECOG, Tx)
• OS K-M curve errors table)
• Unusually smooth PFS w/ 6-wk scans
• Median OS CI “NE” despite est. median; Table 1 p-val inconsistencies
🧭 Questioned methods need full transparency & clarification to restore trust.
• Protocol v1 (Jan 2022) cites 2024 refs → timeline error
• CT.gov record changed: randomized → observational → revised
• Protocol-registry mismatch (endpoints, n, ECOG, Tx)
• OS K-M curve errors table)
• Unusually smooth PFS w/ 6-wk scans
• Median OS CI “NE” despite est. median; Table 1 p-val inconsistencies
🧭 Questioned methods need full transparency & clarification to restore trust.
🕗 LungTIME-C01 | 1L NSCLC (Phase III)
Early immunochemo (<15:00) vs late:
📈 mPFS: 11.3 vs 5.7 mo (HR 0.40)
⏳ mOS: 28.0 vs 16.8 mo (HR 0.42)
🧬 ↑ CD8⁺ activation | similar safety
➡️ Simple chronotherapy may improve outcomes.
🔗 nature.com/articles/s4159…
@OncoAlert
0
2
8
2,723
Augusto_Valdivia retweeted
👋 Hi #sarcoma twitter community
Just wanted to share that I will serve as @JCO_ASCO Editorial Board member 2026-2028
💊 I am looking forward to receiving high-quality papers on sarcoma clinical research!
ascopubs.org/jco/about/edit…
Just wanted to share that I will serve as @JCO_ASCO Editorial Board member 2026-2028
💊 I am looking forward to receiving high-quality papers on sarcoma clinical research!
ascopubs.org/jco/about/edit…
6
6
48
4,760
Augusto_Valdivia retweeted
I am going to continue to fight for this. All government/public funded research should by default be open access. Such an important trial- funded by public money- cannot stay behind a paywall. Public funded the research, now they should pay to read the results? Doesn't make pz1NS2B
8
29
141
13,501
Augusto_Valdivia retweeted
In my humble opinion, the next generation of reviews must be more forward-thinking and give personal views on the topic. This would make our works truly unique
By the way: everyone shows their concerns with AI, but not with medical writers taking over our duty of writing science
By the way: everyone shows their concerns with AI, but not with medical writers taking over our duty of writing science
🆕 Editorial article in press: “Will AI write the next "Chapter" in literature reviews?”
👉annalsofoncology.org/article/S0923-…
@Prof_Koopman
@mihaela_aldea
@jnkath
0
4
25
4,730
Augusto_Valdivia retweeted
Deeply diving into 'seed and soil' model with @SonyaHessey.
- 'Source' mets (met to met) occur early in NSCLC.
-Extrathorax mets derive mainly from extrathoracic seeding clones
-Intrathoracic clones with extrathorax seeding capacity have higher chromosomal instability #ESMOMAP
- 'Source' mets (met to met) occur early in NSCLC.
-Extrathorax mets derive mainly from extrathoracic seeding clones
-Intrathoracic clones with extrathorax seeding capacity have higher chromosomal instability #ESMOMAP
0
3
12
1,669
Augusto_Valdivia retweeted
🌐 Desde #ESMO25, seguimos cubriendo el congreso con el Dr. David Illescas una entrevista clave sobre los avances presentados. 🎥 Sigue toda la cobertura en tiempo real en nuestro canal: oncobites.tv
#Oncología #ESMO2025 #InvestigaciónMédica #Cáncer #OncoBites #CongresoOncológico
#Oncología #ESMO2025 #InvestigaciónMédica #Cáncer #OncoBites #CongresoOncológico
0
2
6
1,094
Augusto_Valdivia retweeted
Want a quick update on what happened yesterday? Come join us for Highlights of the Day session! 🤩
Plus you get to wear some cool 🎧
✨Happening now, in the E poster hall, with @EnriquetaFelip @BenjaminBesseMD Drs. Rafal Dziadziuszko, Fernando Lopez Rio
#WCLC25 @IASLC
Plus you get to wear some cool 🎧
✨Happening now, in the E poster hall, with @EnriquetaFelip @BenjaminBesseMD Drs. Rafal Dziadziuszko, Fernando Lopez Rio
#WCLC25 @IASLC
0
9
33
3,554
Augusto_Valdivia retweeted
.@telediario_tve entrevista Pilar, pacient de càncer de pulmó: la Dra. @EnriquetaFelip, cap d'Oncologia Mèdica de l'hospital #VallHebron i cap del Grup de Tumors Toràcics i Càncer de Cap i Coll del @VHIO, i la Dra. Patricia Iranzo, investigadora del @VHIO, parlen de la malaltia.
A esta unidad llegan cada semana quince nuevos pacientes con cáncer de pulmón
Aunque el índice de supervivencia es cada vez mayor, es una enfermedad cada vez más frecuente.
💬 @_macarenaleon
rtve.es/directo/canal-…
0
2
8
2,633
Augusto_Valdivia retweeted
🧬 Acquired resistance to RAS inhibitors in pancreatic cancer
@Annals_Oncology
✅Insightful data by @Florian_Castet @vicenttianfr @MacarullaTeresa
➡️Common genetic resistant mechanisms with daraxonrasib and G12Ci
❗️Disease site and drug specifity ➡️ resistance mechanism ➡️ e of treatments
👉annalsofoncology.org/article/S0923-…
@myESMO #cancer #oncology #MedX #pancreatic
@Annals_Oncology
✅Insightful data by @Florian_Castet @vicenttianfr @MacarullaTeresa
➡️Common genetic resistant mechanisms with daraxonrasib and G12Ci
❗️Disease site and drug specifity ➡️ resistance mechanism ➡️ e of treatments
👉annalsofoncology.org/article/S0923-…
@myESMO #cancer #oncology #MedX #pancreatic
0
8
13
2,328
Augusto_Valdivia retweeted
The FDA has approved taletrectinib for ROS1+ NSCLC, but what does that mean for clinical practice? On #LungCancerConsidered, @StephenVLiu, @EnriquetaFelip & @nievamd discuss this approval & how to position taletrectinib among treatment options.
🎧 bit.ly/FDATaletrectin…
🎧 bit.ly/FDATaletrectin…
2
11
22
3,203
Augusto_Valdivia retweeted
🚀 As part of @I3lung, VHIO joins the Annual Meeting, leading the way towards personalized oncology through #AI.
The Thoracic Tumors Group, led by @EnriquetaFelip, plays a key role by contributing clinical expertise and leading genomic analysis in this EU-funded initiative ncer treatment.
👉 linke.to/I3LUNGVHIO
The Thoracic Tumors Group, led by @EnriquetaFelip, plays a key role by contributing clinical expertise and leading genomic analysis in this EU-funded initiative ncer treatment.
👉 linke.to/I3LUNGVHIO
0
3
12
1,542
Augusto_Valdivia retweeted
Presented at #ASCO25 and published in @NEJM: Tarlatamab, a DLL3-targeting bispecific T-cell engager, significantly improves overall survival vs chemo in 2L #SCLC (13.6 vs 8.3 mo).
👏 Congrats to VHIO's researcher @pedrofsrocha for contributing to this pivotal trial ‼️
➡️ doi.org/10.1056/NEJMoa…
👏 Congrats to VHIO's researcher @pedrofsrocha for contributing to this pivotal trial ‼️
➡️ doi.org/10.1056/NEJMoa…
2
14
49
3,063
Augusto_Valdivia retweeted
¡Hoy cerramos el 13º Curso de Competencias en Cáncer de Pulmón! 🫁
👉Han sido dos días de aprendizaje intensivo con 12 docentes y la participación de 60 residentes y adjuntos. ¡Gracias a todos por hacerlo posible!
#CáncerDePulmón #CursoCompetencias2025
👉Han sido dos días de aprendizaje intensivo con 12 docentes y la participación de 60 residentes y adjuntos. ¡Gracias a todos por hacerlo posible!
#CáncerDePulmón #CursoCompetencias2025
0
4
17
1,485